Dr. Ajai speaks about the company's incredible journey from inception to where we are today, challenges he overcame, and the milestones achieved during this period. How he wanted to make cancer treatment affordable and accessible to everyone. With this goal in mind, he started a not-for-profit in Mysore, India in 1989, but soon realized the constraints of this location. He decided to build a hub-and-spoke model from Bengaluru instead – whereby there is one main centralized location (the hub) and other smaller spread-out workplaces (the spokes). 

This new model allowed him to create a wider net and reach more patients across India, and soon others began to take note. As HCG kept adding new spokes to its Bengaluru hub, acquisition offers poured in. But Dr. Ajai was firm on his singular goal – making HCG an international-standard cancer treatment facility. In 2016, he took HCG public and made the decision to double down on oncology.  HCG has not only grown as a business, but its strategies for staying ahead of diseases that are ever evolving and complex have also expanded.

To read the complete story, kindly access the below link: 

BS Ajaikumar, Executive Chair of HealthCare Global Enterprises (theceomagazine.com)